Updated
Reviewed
Management of Children Receiving Antiretroviral Therapy
Overview
In the United States, the majority of children with HIV are receiving antiretroviral therapy (ART), making treatment-experienced children the norm. Providers may consider antiretroviral (ARV) regimen changes for the following reasons:
- Treatment simplification: Modifying ARV regimens in children who are currently receiving effective ART in order to simplify the regimen.
- Treatment optimization: Increasing the treatment potency or barrier to resistance of an effective but older or potentially fragile regimen or improving the adverse event profile.
- Toxicity management: Recognizing and managing ARV drug toxicity or intolerance (see Management of Medication Toxicity or Intolerance).
- Treatment failure: Recognizing and managing treatment failure (see Recognizing and Managing Antiretroviral Treatment Failure).
Download Guidelines
-
Full Guideline PDF (6.3 MB)
-
Recommendations Only PDF (244.49 KB)
-
Tables Only PDF (1.05 MB)
-
Drug Tables Only PDF (2.39 MB)